Molecular mechanisms of IL-33-mediated stromal interactions in cancer metastasis.
暂无分享,去创建一个
Yihai Cao | R. Beyaert | Qi Li | P. Andersson | Yin Zhang | Shihai Liu | Mayland Chang | Shuzhen Liu | K. Hosaka | Guohua Yu | Yunlong Yang | H. Braun | Carina Fischer
[1] T. Okinaga,et al. Mechanisms involved in enhancement of matrix metalloproteinase‐9 expression in macrophages by interleukin‐33 , 2017, Journal of cellular physiology.
[2] J. Hartman,et al. A Zebrafish Model Discovers a Novel Mechanism of Stromal Fibroblast-Mediated Cancer Metastasis , 2017, Clinical Cancer Research.
[3] Thomas R. Cox,et al. Pre-metastatic niches: organ-specific homes for metastases , 2017, Nature Reviews Cancer.
[4] J. Hartman,et al. Pericyte–fibroblast transition promotes tumor growth and metastasis , 2016, Proceedings of the National Academy of Sciences.
[5] R. Kalluri. The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.
[6] N. Samani,et al. The PDGF-BB-SOX7 axis-modulated IL-33 in pericytes and stromal cells promotes metastasis through tumour-associated macrophages , 2016, Nature Communications.
[7] I. Keklikoglou,et al. Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy. , 2015, Cancer research.
[8] K. Xie,et al. Pancreatic cancer stromal biology and therapy , 2015, Genes & diseases.
[9] J. Hartman,et al. Novel mechanism of macrophage-mediated metastasis revealed in a zebrafish model of tumor development. , 2015, Cancer research.
[10] R. Milner,et al. Matrix metalloproteinase-9 mediates post-hypoxic vascular pruning of cerebral blood vessels by degrading laminin and claudin-5 , 2014, Angiogenesis.
[11] M. Teixeira,et al. IL-33 targeting attenuates intestinal mucositis and enhances effective tumour chemotherapy in mice , 2014, Mucosal Immunology.
[12] M. Junttila,et al. Influence of tumour micro-environment heterogeneity on therapeutic response , 2013, Nature.
[13] J. Condeelis,et al. Imaging interactions between macrophages and tumour cells that are involved in metastasis in vivo and in vitro , 2013, Journal of microscopy.
[14] Yihai Cao,et al. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis , 2013, Nature Communications.
[15] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[16] Dai Fukumura,et al. Malignant cells facilitate lung metastasis by bringing their own soil , 2010, Proceedings of the National Academy of Sciences.
[17] Malte Buchholz,et al. Stromal biology and therapy in pancreatic cancer , 2010, Gut.
[18] T. Abe,et al. IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.
[19] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[20] Yihai Cao,et al. Improvement of antiangiogenic cancer therapy by understanding the mechanisms of angiogenic factor interplay and drug resistance. , 2009, Seminars in cancer biology.
[21] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[22] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[23] J. Pollard,et al. The EGF/CSF-1 paracrine invasion loop can be triggered by heregulin beta1 and CXCL12. , 2009, Cancer research.
[24] P. Allavena,et al. Cancer-related inflammation , 2008, Nature.
[25] G. Haegeman,et al. Withaferin A Strongly Elicits IκB Kinase β Hyperphosphorylation Concomitant with Potent Inhibition of Its Kinase Activity* , 2007, Journal of Biological Chemistry.
[26] J. Massagué,et al. Cancer Metastasis: Building a Framework , 2006, Cell.
[27] A. Puisieux,et al. Metastasis: a question of life or death , 2006, Nature Reviews Cancer.
[28] John Condeelis,et al. Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.
[29] S. Rafii,et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.
[30] J Fernando Bazan,et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.
[31] J. Pollard,et al. A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors , 2004, Cancer Research.
[32] R. DePinho,et al. Pancreatic cancer biology and genetics , 2002, Nature Reviews Cancer.
[33] K. Umezawa,et al. Molecular design and biological activities of NF-kappaB inhibitors. , 2002, Molecules and cells.
[34] Eric Verdin,et al. Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation , 2001, Science.
[35] L. Kotra,et al. X-ray Absorption Studies of Human Matrix Metalloproteinase-2 (MMP-2) Bound to a Highly Selective Mechanism-based Inhibitor , 2001, The Journal of Biological Chemistry.
[36] D. J. Matthews,et al. T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses , 2000, The Journal of experimental medicine.
[37] J. Pollard. Tumour-educated macrophages promote tumour progression and metastasis , 2004, Nature Reviews Cancer.
[38] W. Greene,et al. Duration of nuclear NF-kappaB action regulated by reversible acetylation. , 2001, Science.